SCOTTSDALE, AZ / ACCESSWIRE / February 2, 2022 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. announces today that the company is going to be starting production of HHC products within the next week.
With the cannabinoid space race at full throttle, alternatives to conventional Delta-9 THC and CBD emerge thick and fast. HHC is one of the more recent cannabinoids to appear on the market. Hydroxyhexahydrocannabinol, or HHC, is a hydrogenated form of THC. This is a similar process used to turn vegetable oil into margarine using a process called hydrogenation (adding hydrogen atoms to the chemical structure to stabilize it). HHC is also the most stable form of THC as it is super resistant to oxidation, heat, and UV Light. In addition, HHC is less powerful than Delta-9 THC but more potent than Delta-8 THC. President & CEO Lisa Nelson states "Producing HHC products will bring us to a whole new level, and it will be very beneficial to our elder customers who deal with chronic pain on a daily basis due to HHC's potency." Overall, HHC calms the whole body and mind while giving you the feeling of euphoria. It may help with inflammation, lack of energy, mental clarity, nausea, and pain. Moreover, it comes in different strains and favors. HHC products are available in the form of vapes, hemp flowers, and pre-rolled joints only as of right now. CBD Life Sciences Inc. is always trying to stay ahead of its competitors in numerous ways and the company is off to a great start as 2022 progresses.
The number of benefits CBD has is tremendous! These benefits may help with behavioral/neurological complications such as ADD/ADHD, anxiety, autism, bipolar, OCD, PTSD, epilepsy, Parkinson's, osteoporosis, and ALS. CBD may also benefit pain management that can stem from headaches/migraines, arthritis, cramps, spinal injuries, and fibromyalgia. CBD has been found to also have gastrointestinal benefits with gastro-disorders and complications such as anorexia, cachexia, Crohn's, diabetes, and nausea. Physical complications/disorders such as muscular dystrophy and even immune system-based deficiencies and other complications such as cancer and hypertension even our bodies way and ability to maintain homeostasis have all been said to benefit from CBD.
LBC BIOSCIENCE INC. ONLINE STORE
LBC BIOSCIENCE'S Online Emporium
LBC Bioscience Inc. is well stocked already as it is with some very high-quality CBD offerings - all at very reasonable prices. Check out LBC Bioscience Inc's newest product offerings including its: 100MG CBD Bath Bombs in a variety of scents, Delta 8 Gummies, 1500 MG Premium Berry Drops, and a variety of all-new Skincare products. Or shop our top selling products (based on order frequency) which include our CBD Pain Cream, CBD Oils and CBD Pet Treats.
Become a Distributor
- Large Selection of Products (over 50 items and growing)
- 100% USA Made Products "organic & kosher."
- All Products are THC-FREE (they contain 0.00% THC)
- Weekly Deals (new deals every week)
- 25% off on all products using code "LBC25."
LBC Bioscience Inc. accepts: Visa, MasterCard, American Express, Discover etc.
Shareholders and interest holders may also stay current with LBC Bioscience Inc Updates:
LBC Bioscience Inc's Main Website at www.lbcbioscienceinc.com
About LBC Bioscience Inc.
LBC Bioscience Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. LBC has developed and is retailing/wholesale a full line of cannabidiol based organic products including CBD Drops, Gumballs, Honey Sticks, Pain Relief Creams, Anxiety & Sleep Supplements, Edibles, Coffee, Skincare Line, Pet Line, Tablets and more. LBC's products can be viewed and purchased on the Company's website at www.lbcbioscienceinc.com.
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking.
SOURCE: CBD Life Sciences Inc.